Methodological issues in assessing changes in costs pre- and post-medication switch: a schizophrenia study example
-
* Corresponding author: Douglas E Faries d.faries@lilly.com
Cost Effectiveness and Resource Allocation 2009, 7:11 doi:10.1186/1478-7547-7-11
No comments have yet been made on this article.